Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.29 trillion and total revenue of $109.84 billion.
Market Cap
1.29T
Revenue
109.84B
Profits
-41.24B
PE Ratio
n/a
Profit Margin
-37.54%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 134.41B | 0.29% | 1,515,704 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 66.11B | -0.68% | 714,320 | 14.92B |
| 3 | ARGX | argenx SE | 57.73B | -2.43% | 266,484 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.79B | 0.08% | 891,834 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.39B | 0.40% | 2,398,276 | - |
| 6 | ONC | BeOne Medicines AG | 34.40B | 3.97% | 405,302 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 32.78B | -1.47% | 3,105,914 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 32.46B | 2.56% | 17,296,868 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.45B | 0.74% | 5,977,226 | 8.26M |
| 10 | INSM | Insmed Incorporated | 24.18B | -0.05% | 2,232,434 | 819.56M |
| 11 | BNTX | BioNTech SE | 23.75B | -3.71% | 784,889 | 3.23B |
| 12 | INCY | Incyte Corporation | 23.10B | -1.06% | 1,260,807 | 5.36B |
| 13 | GMAB | Genmab A/S | 17.14B | -1.77% | 1,778,657 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.64B | -2.40% | 547,093 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.34B | 0.29% | 861,882 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.23B | 0.73% | 3,137,227 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.96B | -0.57% | 3,233,775 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 13.75B | 1.69% | 1,847,295 | 1.06B |
| 19 | ABVX | ABIVAX Société Anonyme | 12.69B | -0.46% | 1,544,827 | 5.67M |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.48B | -0.70% | 842,382 | 708.24M |
| 21 | SMMT | Summit Therapeutics Inc. | 12.36B | 3.31% | 3,922,125 | - |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.21B | 0.26% | 230,982 | 1.13B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.19B | 3.05% | 2,445,786 | 622.01M |
| 24 | CYTK | Cytokinetics, Incorporated | 11.62B | -1.06% | 2,239,317 | 105.82M |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 11.36B | -0.34% | 1,789,110 | 3.24B |
| 26 | TECH | Bio-Techne Corporation | 11.05B | 0.13% | 6,778,471 | 1.21B |
| 27 | KRYS | Krystal Biotech, Inc. | 11.05B | -0.10% | 191,350 | 417.30M |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.01B | 0.44% | 1,595,459 | - |
| 29 | CORT | Corcept Therapeutics Incorporated | 9.83B | 1.55% | 1,171,696 | 769.10M |
| 30 | NUVL | Nuvalent, Inc. | 9.77B | -0.01% | 1,817,042 | - |
| 31 | HALO | Halozyme Therapeutics, Inc. | 9.58B | 1.67% | 2,504,835 | 1.51B |
| 32 | KYMR | Kymera Therapeutics, Inc. | 9.44B | 1.10% | 625,151 | 51.48M |
| 33 | IBRX | ImmunityBio, Inc. | 9.33B | -5.61% | 13,475,977 | 140.98M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | -1.58% | 401,165 | 7.46M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.46B | -0.09% | 640,082 | 74.06M |
| 36 | PCVX | Vaxcyte, Inc. | 8.22B | -2.45% | 1,310,612 | - |
| 37 | IMVT | Immunovant, Inc. | 7.92B | -0.49% | 1,066,372 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.86B | 4.05% | 2,700,151 | 700.35M |
| 39 | SYRE | Spyre Therapeutics, Inc. | 7.71B | 2.44% | 1,388,659 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.65B | -2.18% | 672,630 | 217.17M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.43B | -2.93% | 449,255 | 569.61M |
| 42 | PTCT | PTC Therapeutics, Inc. | 7.09B | 2.56% | 3,806,488 | 827.11M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.74B | 1.94% | 1,465,321 | - |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.63B | 0.87% | 1,182,357 | - |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 6.35B | 0.27% | 349,436 | 274.48M |
| 46 | CGON | CG Oncology, Inc. | 6.11B | -1.56% | 526,081 | 5.07M |
| 47 | BLTE | Belite Bio, Inc | 6.06B | 5.04% | 214,296 | - |
| 48 | CRSP | CRISPR Therapeutics AG | 5.97B | 3.01% | 2,050,999 | 4.10M |
| 49 | DFTX | Definium Therapeutics, Inc. | 5.88B | 0.32% | 2,075,404 | - |
| 50 | ERAS | Erasca, Inc. | 5.86B | 2.06% | 4,539,569 | - |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.85B | -0.69% | 1,734,798 | 7.50M |
| 52 | LEGN | Legend Biotech Corporation | 5.42B | -6.25% | 1,525,848 | 1.14B |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.35B | 0.98% | 1,866,441 | 536.20M |
| 54 | CELC | Celcuity Inc. | 5.30B | 0.58% | 1,137,655 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 5.10B | -1.06% | 857,830 | 1.34M |
| 56 | MANE | Veradermics, Incorporated | 5.10B | -5.91% | 542,619 | - |
| 57 | CAI | Caris Life Sciences, Inc. | 5.03B | -2.68% | 2,611,052 | 907.29M |
| 58 | ORKA | Oruka Therapeutics, Inc. | 5.01B | -2.44% | 1,579,405 | - |
| 59 | VKTX | Viking Therapeutics, Inc. | 4.49B | 3.39% | 2,122,110 | - |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.43B | -0.47% | 5,423,474 | 18.07M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 4.41B | -0.77% | 1,154,964 | 1.10B |
| 62 | TNGX | Tango Therapeutics, Inc. | 4.33B | 1.63% | 2,142,406 | 56.99M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 4.31B | 1.37% | 511,246 | - |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.12B | 1.34% | 3,147,259 | 10.68M |
| 65 | TLX | Telix Pharmaceuticals Limited | 4.09B | 2.36% | 201,489 | 803.79M |
| 66 | DNLI | Denali Therapeutics Inc. | 4.09B | -0.35% | 1,335,401 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 4.08B | 0.20% | 932,485 | 22.57M |
| 68 | GPCR | Structure Therapeutics Inc. | 3.89B | 2.43% | 510,520 | - |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.86B | 0.16% | 923,717 | 596.96M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.78B | -0.91% | 2,919,526 | - |
| 71 | RCUS | Arcus Biosciences, Inc. | 3.77B | -1.15% | 762,037 | 236.00M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.74B | 4.57% | 1,772,857 | 225.27M |
| 73 | PBLS | Parabilis Medicines, Inc. | 3.72B | -1.28% | 281,863 | - |
| 74 | BEAM | Beam Therapeutics Inc. | 3.52B | 1.52% | 2,404,218 | 164.01M |
| 75 | ELVN | Enliven Therapeutics, Inc. | 3.49B | 0.38% | 748,098 | - |
| 76 | ALMS | Alumis Inc. | 3.48B | 2.91% | 1,404,916 | 8.40M |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 3.31B | 0.69% | 1,553,100 | 670.00M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | 1.01% | 1,290,399 | 415.62M |
| 79 | KLRA | Kailera Therapeutics, Inc. | 3.02B | 5.96% | 482,534 | - |
| 80 | CLDX | Celldex Therapeutics, Inc. | 2.98B | -1.09% | 470,282 | 865.00K |
| 81 | IRON | Disc Medicine, Inc. | 2.94B | 0.98% | 988,763 | - |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.88B | 2.32% | 1,287,334 | 535.08M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.88B | -2.60% | 2,880,053 | - |
| 84 | QURE | uniQure N.V. | 2.84B | -1.08% | 1,113,874 | 18.09M |
| 85 | MBX | MBX Biosciences, Inc. | 2.75B | -0.17% | 603,011 | - |
| 86 | IMNM | Immunome, Inc. | 2.71B | 1.23% | 1,783,871 | 4.02M |
| 87 | SLS | SELLAS Life Sciences Group, Inc. | 2.59B | -6.94% | 9,746,734 | - |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.57B | 5.16% | 1,717,241 | - |
| 89 | TRVI | Trevi Therapeutics, Inc. | 2.55B | 0.11% | 2,369,239 | - |
| 90 | NTLA | Intellia Therapeutics, Inc. | 2.49B | 1.59% | 3,845,751 | 66.09M |
| 91 | NRIX | Nurix Therapeutics, Inc. | 2.49B | 0.29% | 744,851 | 71.78M |
| 92 | NKTR | Nektar Therapeutics | 2.47B | 2.97% | 1,086,680 | 55.63M |
| 93 | BHVN | Biohaven Ltd. | 2.42B | 0.56% | 1,945,774 | - |
| 94 | ABCL | AbCellera Biologics Inc. | 2.40B | -2.96% | 6,311,092 | 79.21M |
| 95 | VCEL | Vericel Corporation | 2.38B | -0.89% | 524,531 | 292.09M |
| 96 | PHVS | Pharvaris N.V. | 2.32B | -1.89% | 753,087 | - |
| 97 | KOD | Kodiak Sciences Inc. | 2.31B | -3.94% | 436,210 | - |
| 98 | AGIO | Agios Pharmaceuticals, Inc. | 2.23B | -0.43% | 476,102 | 66.05M |
| 99 | GENB | Generate Biomedicines, Inc. | 2.17B | -2.81% | 1,042,212 | 30.30M |
| 100 | ZLAB | Zai Lab Limited | 2.14B | -0.21% | 528,587 | 453.28M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.14B | -0.67% | 443,802 | 899.11M |
| 102 | KARD | Kardigan, Inc. | 2.12B | -2.34% | 304,722 | - |
| 103 | ADMA | ADMA Biologics, Inc. | 2.12B | 2.35% | 2,620,441 | 509.86M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 2.12B | 0.21% | 2,407,616 | 52.04M |
| 105 | RXRX | Recursion Pharmaceuticals, Inc. | 2.10B | 4.21% | 38,065,212 | 66.41M |
| 106 | VRDN | Viridian Therapeutics, Inc. | 2.10B | -2.11% | 1,725,584 | 70.92M |
| 107 | TSHA | Taysha Gene Therapies, Inc. | 2.04B | -2.30% | 1,745,173 | 7.47M |
| 108 | NBTX | Nanobiotix S.A. | 2.04B | 7.03% | 334,190 | 38.27M |
| 109 | SRPT | Sarepta Therapeutics, Inc. | 2.02B | -0.52% | 2,846,744 | 2.18B |
| 110 | STOK | Stoke Therapeutics, Inc. | 2.02B | -0.83% | 696,902 | 32.08M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 2.01B | -4.39% | 197,519 | - |
| 112 | PGEN | Precigen, Inc. | 2.00B | -0.71% | 5,158,075 | 31.60M |
| 113 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -0.77% | 1,802,217 | 298.30M |
| 114 | LKFT | Lakefront Biotherapeutics NV | 1.99B | -0.10% | 101,559 | 1.20B |
| 115 | GLUE | Monte Rosa Therapeutics, Inc. | 1.96B | -3.97% | 996,182 | 42.95M |
| 116 | SNDX | Syndax Pharmaceuticals, Inc. | 1.96B | 1.19% | 1,571,953 | 217.17M |
| 117 | ABSI | Absci Corporation | 1.95B | -0.69% | 5,484,576 | 1.84M |
| 118 | NUVB | Nuvation Bio Inc. | 1.95B | -1.75% | 5,518,773 | 143.05M |
| 119 | SION | Sionna Therapeutics, Inc. | 1.95B | -1.98% | 255,810 | - |
| 120 | BCAX | Bicara Therapeutics Inc. | 1.92B | 0.76% | 531,312 | - |
| 121 | IOVA | Iovance Biotherapeutics, Inc. | 1.87B | -2.78% | 12,775,613 | 285.61M |
| 122 | MESO | Mesoblast Limited | 1.87B | -0.35% | 107,124 | 65.38M |
| 123 | ZYME | Zymeworks Inc. | 1.85B | -3.72% | 622,914 | 81.26M |
| 124 | ANAB | AnaptysBio, Inc. | 1.84B | -1.75% | 559,584 | 232.39M |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.84B | -1.03% | 266,973 | 20.00M |
| 126 | TYRA | Tyra Biosciences, Inc. | 1.84B | 0.78% | 419,268 | - |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.83B | -0.60% | 725,339 | - |
| 128 | ATAI | AtaiBeckley Inc. | 1.83B | -4.43% | 11,594,383 | 3.49M |
| 129 | URGN | UroGen Pharma Ltd. | 1.82B | -1.60% | 845,633 | 140.49M |
| 130 | GHRS | GH Research PLC | 1.80B | -3.11% | 118,876 | - |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.79B | 3.49% | 592,131 | 20.00M |
| 132 | AAPG | Ascentage Pharma Group International | 1.72B | 4.70% | 12,914 | 82.08M |
| 133 | VIR | Vir Biotechnology, Inc. | 1.69B | -0.20% | 1,569,839 | 65.50M |
| 134 | FTRE | Fortrea Holdings Inc. | 1.69B | 3.30% | 923,680 | 2.71B |
| 135 | ZBIO | Zenas BioPharma, Inc. | 1.67B | -2.86% | 605,318 | 10.00M |
| 136 | IMCR | Immunocore Holdings plc | 1.62B | -1.72% | 289,630 | 412.81M |
| 137 | INVA | Innoviva, Inc. | 1.61B | -2.20% | 660,419 | 420.69M |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.61B | -0.52% | 467,321 | - |
| 139 | MPLT | MapLight Therapeutics, Inc. | 1.59B | -5.53% | 234,384 | - |
| 140 | SVRA | Savara Inc. | 1.57B | -0.32% | 1,334,838 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.56B | -0.37% | 959,777 | - |
| 142 | NVAX | Novavax, Inc. | 1.54B | -4.00% | 2,958,091 | 596.34M |
| 143 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.52B | -2.32% | 2,369,551 | 204.73M |
| 144 | SEPN | Septerna, Inc. | 1.51B | -1.56% | 469,404 | 72.26M |
| 145 | AKTS | Aktis Oncology, Inc. | 1.47B | -16.37% | 886,712 | 8.28M |
| 146 | INBX | Inhibrx Biosciences, Inc. | 1.43B | -0.45% | 527,701 | 1.30M |
| 147 | COAG | Hemab Therapeutics Holdings, Inc. | 1.40B | -3.32% | 618,121 | - |
| 148 | IMTX | Immatics N.V. | 1.37B | 0.40% | 837,218 | 43.00M |
| 149 | MNKD | MannKind Corporation | 1.32B | -5.53% | 4,082,954 | 360.78M |
| 150 | ARDX | Ardelyx, Inc. | 1.32B | 1.33% | 3,612,995 | 427.68M |
| 151 | CAPR | Capricor Therapeutics, Inc. | 1.30B | -3.36% | 2,126,808 | 11.13M |
| 152 | MGTX | MeiraGTx Holdings plc | 1.29B | -0.22% | 656,938 | 79.76M |
| 153 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | -0.39% | 1,085,263 | - |
| 154 | JBIO | Jade Biosciences, Inc. | 1.26B | -0.98% | 1,056,288 | - |
| 155 | AVLN | Avalyn Pharma Inc. | 1.23B | -7.00% | 518,809 | - |
| 156 | DRTS | Alpha Tau Medical Ltd. | 1.22B | 2.61% | 1,623,954 | - |
| 157 | WVE | Wave Life Sciences Ltd. | 1.22B | 0.96% | 3,000,277 | 71.80M |
| 158 | EYPT | EyePoint, Inc. | 1.21B | 3.29% | 1,589,216 | 7.61M |
| 159 | SANA | Sana Biotechnology, Inc. | 1.19B | -1.00% | 3,415,295 | - |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | -6.27% | 2,622,011 | - |
| 161 | OLMA | Olema Pharmaceuticals, Inc. | 1.12B | 1.03% | 1,220,876 | - |
| 162 | XNCR | Xencor, Inc. | 1.10B | -0.67% | 504,887 | 97.36M |
| 163 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | 1.02% | 771,684 | - |
| 164 | SLDB | Solid Biosciences Inc. | 1.09B | 2.12% | 2,851,158 | - |
| 165 | VOR | Vor Biopharma Inc. | 1.09B | -2.38% | 1,594,942 | - |
| 166 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 5.94% | 1,615,154 | 59.00K |
| 167 | SPTX | Seaport Therapeutics, Inc. | 1.04B | -5.83% | 141,856 | - |
| 168 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | - | 2,219,278 | 69.64M |
| 169 | PHAR | Pharming Group N.V. | 992.29M | 2.90% | 10,295 | 369.49M |
| 170 | ABUS | Arbutus Biopharma Corporation | 981.76M | 2.05% | 2,815,071 | 191.45M |
| 171 | KURA | Kura Oncology, Inc. | 980.07M | -0.54% | 1,351,228 | 71.64M |
| 172 | ANNX | Annexon, Inc. | 976.50M | 9.16% | 6,778,986 | - |
| 173 | REPL | Replimune Group, Inc. | 962.85M | -0.95% | 1,634,686 | - |
| 174 | LBRX | LB Pharmaceuticals Inc | 958.37M | -0.03% | 232,707 | - |
| 175 | JANX | Janux Therapeutics, Inc. | 939.77M | -0.84% | 607,454 | 13.73M |
| 176 | DBVT | DBV Technologies S.A. | 937.95M | -1.33% | 159,101 | 5.74M |
| 177 | DSGN | Design Therapeutics, Inc. | 927.49M | -5.05% | 949,407 | - |
| 178 | GERN | Geron Corporation | 923.79M | 5.88% | 11,315,316 | 196.12M |
| 179 | IVA | Inventiva S.A. | 921.33M | -0.26% | 3,001,037 | 7.94M |
| 180 | ANRO | Alto Neuroscience, Inc. | 920.16M | 5.81% | 677,637 | - |
| 181 | PHAT | Phathom Pharmaceuticals, Inc. | 903.91M | 1.61% | 835,779 | 204.89M |
| 182 | TBPH | Theravance Biopharma, Inc. | 876.40M | 0.41% | 596,962 | 109.78M |
| 183 | OCS | Oculis Holding AG | 833.36M | -2.27% | 378,625 | 1.40M |
| 184 | TENX | Tenax Therapeutics, Inc. | 830.75M | 5.17% | 1,518,726 | - |
| 185 | CTMX | CytomX Therapeutics, Inc. | 829.45M | -0.26% | 3,200,157 | 35.54M |
| 186 | SPRY | ARS Pharmaceuticals, Inc. | 827.20M | -2.69% | 1,124,311 | 98.99M |
| 187 | ZVRA | Zevra Therapeutics, Inc. | 825.84M | -0.07% | 1,006,074 | 122.29M |
| 188 | ODTX | Odyssey Therapeutics, Inc. | 788.79M | -1.93% | 154,724 | 1.06M |
| 189 | AURA | Aura Biosciences, Inc. | 782.02M | -8.40% | 677,877 | - |
| 190 | ACRS | Aclaris Therapeutics, Inc. | 766.75M | -1.26% | 1,193,633 | 8.37M |
| 191 | RGNX | REGENXBIO Inc. | 766.68M | 11.67% | 3,152,587 | 87.82M |
| 192 | SLBT | SL Science Holding Limited | 762.06M | -21.29% | 332,248 | - |
| 193 | CLYM | Climb Bio, Inc. | 759.85M | 2.87% | 2,292,982 | - |
| 194 | OMER | Omeros Corporation | 748.36M | 11.42% | 1,745,282 | 9.89M |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 744.80M | 3.96% | 378,419 | 299.77M |
| 196 | IMMX | Immix Biopharma, Inc. | 743.93M | 1.06% | 1,322,631 | - |
| 197 | CADL | Candel Therapeutics, Inc. | 734.90M | 2.03% | 1,075,387 | - |
| 198 | ALLO | Allogene Therapeutics, Inc. | 721.37M | 0.48% | 10,911,873 | 22.00K |
| 199 | PRME | Prime Medicine, Inc. | 720.66M | 3.10% | 4,111,957 | 4.03M |
| 200 | TRAX | First Tracks Biotherapeutics, Inc. | 699.24M | 3.83% | 588,281 | - |
| 201 | CRMD | CorMedix Inc. | 689.59M | 0.46% | 1,180,426 | 400.05M |
| 202 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 673.70M | 3.70% | 263,881 | - |
| 203 | AGMB | AgomAb Therapeutics NV | 669.67M | 7.49% | 107,116 | - |
| 204 | FDMT | 4D Molecular Therapeutics, Inc. | 664.95M | -2.15% | 874,299 | 88.24M |
| 205 | TECX | Tectonic Therapeutic, Inc. | 664.57M | -7.14% | 244,335 | - |
| 206 | RLMD | Relmada Therapeutics, Inc. | 663.96M | 0.80% | 1,243,396 | - |
| 207 | GYRE | Gyre Therapeutics, Inc. | 663.36M | -1.09% | 133,218 | 117.05M |
| 208 | ACHV | Achieve Life Sciences, Inc. | 662.15M | 0.78% | 1,301,798 | - |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 660.43M | -2.79% | 1,391,652 | 151.40M |
| 210 | DRUG | Bright Minds Biosciences Inc. | 652.75M | -1.41% | 320,841 | - |
| 211 | EIKN | Eikon Therapeutics, Inc. | 651.56M | -4.03% | 516,685 | - |
| 212 | MNPR | Monopar Therapeutics Inc. | 650.59M | -0.69% | 103,867 | - |
| 213 | NGNE | Neurogene Inc. | 648.82M | -7.87% | 230,143 | 925.00K |
| 214 | SGP | SpyGlass Pharma, Inc. | 638.24M | -0.31% | 127,514 | - |
| 215 | FTH | Faeth Therapeutics, Inc. | 629.00M | 6.46% | 72,001 | - |
| 216 | NVCT | Nuvectis Pharma, Inc. | 618.85M | 0.31% | 572,416 | - |
| 217 | MDXG | MiMedx Group, Inc. | 606.21M | 3.04% | 890,553 | 389.42M |
| 218 | PROK | ProKidney Corp. | 601.10M | -1.97% | 1,145,161 | 889.00K |
| 219 | ALT | Altimmune, Inc. | 598.98M | -2.53% | 4,348,091 | 36.00K |
| 220 | CTNM | Contineum Therapeutics, Inc. | 580.80M | 2.88% | 392,793 | - |
| 221 | ASMB | Assembly Biosciences, Inc. | 572.62M | 4.16% | 179,400 | 71.10M |
| 222 | CBIO | Crescent Biopharma, Inc. | 563.56M | -0.76% | 204,123 | 11.88M |
| 223 | EDIT | Editas Medicine, Inc. | 560.14M | - | 2,951,101 | 38.69M |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 556.88M | 3.04% | 950,655 | - |
| 225 | STTK | Shattuck Labs, Inc. | 555.17M | 2.70% | 1,103,418 | 1.00M |
| 226 | XOMA | XOMA Royalty Corporation | 549.92M | 1.98% | 209,008 | 48.56M |
| 227 | ARVN | Arvinas, Inc. | 545.20M | 0.72% | 617,144 | 89.40M |
| 228 | RZLT | Rezolute, Inc. | 515.02M | 0.41% | 1,629,306 | - |
| 229 | ZURA | Zura Bio Limited | 509.19M | 3.68% | 926,315 | - |
| 230 | STRO | Sutro Biopharma, Inc. | 507.55M | 0.66% | 382,467 | 99.61M |
| 231 | OCGN | Ocugen, Inc. | 504.40M | -1.32% | 5,463,006 | 4.47M |
| 232 | VALN | Valneva SE | 500.21M | 3.25% | 20,683 | 180.25M |
| 233 | SLN | Silence Therapeutics plc | 499.74M | 1.83% | 578,918 | 839.00K |
| 234 | FBRX | Forte Biosciences, Inc. | 498.73M | -2.44% | 242,497 | - |
| 235 | PRTA | Prothena Corporation plc | 497.36M | -1.96% | 403,737 | 57.94M |
| 236 | PRLD | Prelude Therapeutics Incorporated | 494.90M | 1.63% | 241,242 | 16.72M |
| 237 | CABA | Cabaletta Bio, Inc. | 490.79M | -5.64% | 7,799,353 | - |
| 238 | OVID | Ovid Therapeutics Inc. | 487.13M | -2.97% | 1,155,658 | 7.12M |
| 239 | SGMT | Sagimet Biosciences Inc. | 477.96M | 1.71% | 835,695 | - |
| 240 | ARTV | Artiva Biotherapeutics, Inc. | 458.67M | -1.77% | 839,731 | 251.00K |
| 241 | CCCC | C4 Therapeutics, Inc. | 457.75M | -3.72% | 1,904,677 | 34.86M |
| 242 | BNTC | Benitec Biopharma Inc. | 453.48M | -0.15% | 152,597 | - |
| 243 | EVMN | Evommune, Inc. | 445.19M | -4.63% | 988,010 | 10.00M |
| 244 | ANL | Adlai Nortye Ltd. | 436.80M | 15.07% | 299,419 | 5.00M |
| 245 | RCKT | Rocket Pharmaceuticals, Inc. | 435.68M | 3.91% | 3,192,616 | - |
| 246 | AUTL | Autolus Therapeutics plc | 433.81M | 3.16% | 1,039,035 | 92.62M |
| 247 | IPSC | Century Therapeutics, Inc. | 432.85M | -1.23% | 1,027,362 | 109.16M |
| 248 | DMAC | DiaMedica Therapeutics Inc. | 431.61M | 5.12% | 478,527 | - |
| 249 | VTVT | vTv Therapeutics Inc. | 428.69M | -2.42% | 29,903 | 36.84M |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.36M | -2.47% | 277,217 | - |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 421.93M | -3.97% | 204,960 | 69.21M |
| 252 | PBYI | Puma Biotechnology, Inc. | 418.39M | -0.48% | 444,214 | 227.18M |
| 253 | CMPX | Compass Therapeutics, Inc. | 412.40M | 0.88% | 2,481,789 | 850.00K |
| 254 | UPB | Upstream Bio, Inc. | 402.71M | -1.46% | 357,006 | 3.32M |
| 255 | VSTM | Verastem, Inc. | 391.92M | -0.89% | 1,811,452 | 49.59M |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 389.73M | -2.21% | 349,884 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 380.11M | -2.42% | 542,461 | 9.01M |
| 258 | VNDA | Vanda Pharmaceuticals Inc. | 374.64M | 0.32% | 593,775 | 217.78M |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 371.34M | -0.09% | 151,551 | 51.00M |
| 260 | HELP | Cybin Inc. | 365.09M | -5.61% | 769,953 | - |
| 261 | LXEO | Lexeo Therapeutics, Inc. | 361.20M | -1.92% | 696,178 | - |
| 262 | ABEO | Abeona Therapeutics Inc. | 359.64M | -1.41% | 1,418,251 | 14.54M |
| 263 | PALI | Palisade Bio, Inc. | 354.10M | -2.86% | 4,089,308 | - |
| 264 | OABI | OmniAb, Inc. | 349.38M | -0.41% | 607,380 | 28.94M |
| 265 | FATE | Fate Therapeutics, Inc. | 348.51M | 2.40% | 3,394,294 | 6.32M |
| 266 | LRMR | Larimar Therapeutics, Inc. | 343.42M | 0.92% | 1,750,828 | - |
| 267 | IKT | Inhibikase Therapeutics, Inc. | 337.44M | -0.50% | 413,660 | 1.00 |
| 268 | ZNTL | Zentalis Pharmaceuticals, Inc. | 336.00M | 5.83% | 993,965 | 26.87M |
| 269 | IMRX | Immuneering Corporation | 332.54M | -0.96% | 834,616 | - |
| 270 | LCTX | Lineage Cell Therapeutics, Inc. | 331.57M | -1.48% | 842,935 | 14.78M |
| 271 | IRD | Opus Genetics, Inc. | 331.28M | -3.78% | 873,414 | 11.98M |
| 272 | LYEL | Lyell Immunopharma, Inc. | 327.61M | -0.07% | 213,911 | 31.00K |
| 273 | INDP | Indaptus Therapeutics, Inc. | 322.74M | -5.94% | 92,750 | - |
| 274 | NMRA | Neumora Therapeutics, Inc. | 313.13M | 1.20% | 732,189 | - |
| 275 | IFRX | InflaRx N.V. | 310.79M | -5.80% | 987,228 | 33.82K |
| 276 | ELDN | Eledon Pharmaceuticals, Inc. | 306.89M | 0.51% | 1,704,213 | - |
| 277 | GALT | Galectin Therapeutics Inc. | 304.92M | 2.66% | 518,715 | - |
| 278 | RNAC | Cartesian Therapeutics, Inc. | 303.80M | -2.36% | 124,896 | 1.78M |
| 279 | BCYC | Bicycle Therapeutics plc | 303.68M | - | 234,066 | 63.50M |
| 280 | GLSI | Greenwich LifeSciences, Inc. | 300.02M | -7.09% | 215,391 | - |
| 281 | SABS | SAB Biotherapeutics, Inc. | 299.74M | - | 697,846 | 114.70K |
| 282 | FHTX | Foghorn Therapeutics Inc. | 295.33M | -5.09% | 360,214 | 28.22M |
| 283 | ALXO | ALX Oncology Holdings Inc. | 294.69M | 5.80% | 1,386,799 | - |
| 284 | MGNX | MacroGenics, Inc. | 290.48M | -2.97% | 833,589 | 157.08M |
| 285 | CNXU | Conexeu Sciences Inc. | 288.99M | -0.55% | 41,085 | - |
| 286 | NAGE | Niagen Bioscience, Inc. | 279.34M | 2.04% | 608,384 | 130.42M |
| 287 | SRZN | Surrozen, Inc. | 274.70M | -5.14% | 67,355 | 7.49M |
| 288 | TRDA | Entrada Therapeutics, Inc. | 271.33M | -2.14% | 259,369 | 5.74M |
| 289 | ADAG | Adagene Inc. | 259.67M | -12.08% | 379,744 | 7.67M |
| 290 | ACIU | AC Immune SA | 248.99M | - | 269,166 | 4.62M |
| 291 | FULC | Fulcrum Therapeutics, Inc. | 247.88M | -3.12% | 1,490,178 | 80.00M |
| 292 | AVXL | Anavex Life Sciences Corp. | 246.51M | -3.62% | 636,985 | - |
| 293 | IVVD | Invivyd, Inc. | 245.70M | -6.69% | 2,392,605 | 55.87M |
| 294 | OBIO | Orchestra BioMed Holdings, Inc. | 243.71M | -2.86% | 266,534 | 32.72M |
| 295 | PRQR | ProQR Therapeutics N.V. | 242.72M | -4.97% | 766,865 | 15.73M |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 242.30M | 0.15% | 21,090 | 18.47M |
| 297 | CDXS | Codexis, Inc. | 241.78M | 7.69% | 810,598 | 78.09M |
| 298 | CHRS | Coherus Oncology, Inc. | 240.63M | 7.59% | 1,535,256 | 46.88M |
| 299 | NKTX | Nkarta, Inc. | 236.10M | 2.48% | 992,186 | - |
| 300 | CLLS | Cellectis S.A. | 233.94M | -0.30% | 11,478 | 75.11M |
| 301 | NBP | NovaBridge Biosciences | 232.45M | -6.07% | 873,284 | - |
| 302 | TARA | Protara Therapeutics, Inc. | 229.31M | 0.49% | 409,531 | - |
| 303 | NERV | Minerva Neurosciences, Inc. | 229.22M | -3.53% | 239,551 | - |
| 304 | TTRX | Turn Therapeutics Inc. | 229.07M | 8.01% | 100,578 | - |
| 305 | NGEN | NervGen Pharma Corp. | 224.09M | -0.47% | 424,605 | - |
| 306 | CGEN | Compugen Ltd. | 223.22M | 3.51% | 331,201 | 72.66M |
| 307 | RNA | Atrium Therapeutics, Inc. | 222.54M | -4.69% | 206,744 | 36.68M |
| 308 | CAMP | Camp4 Therapeutics Corporation | 222.24M | -3.39% | 162,971 | 3.93M |
| 309 | VYGR | Voyager Therapeutics, Inc. | 218.73M | -4.23% | 556,176 | 36.49M |
| 310 | NAUT | Nautilus Biotechnology, Inc. | 218.58M | -0.58% | 808,652 | - |
| 311 | KROS | Keros Therapeutics, Inc. | 218.30M | -2.04% | 208,996 | 33.18M |
| 312 | KPTI | Karyopharm Therapeutics Inc. | 218.24M | 0.31% | 288,088 | 151.12M |
| 313 | QTTB | Q32 Bio Inc. | 218.14M | -1.72% | 247,340 | 53.74M |
| 314 | WHWK | Whitehawk Therapeutics, Inc. | 216.21M | -4.06% | 523,831 | 7.15M |
| 315 | ALEC | Alector, Inc. | 215.39M | -5.83% | 588,486 | 18.42M |
| 316 | DTIL | Precision BioSciences, Inc. | 212.35M | 0.61% | 424,624 | 45.07M |
| 317 | ARCT | Arcturus Therapeutics Holdings Inc. | 208.91M | 0.96% | 549,459 | 54.71M |
| 318 | HUMA | Humacyte, Inc. | 207.78M | 8.54% | 9,492,137 | 2.02M |
| 319 | KRRO | Korro Bio, Inc. | 202.78M | 0.43% | 463,577 | 3.84M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 202.61M | 3.00% | 188,483 | 17.56M |
| 321 | IMUX | Immunic, Inc. | 202.42M | 0.41% | 87,736 | - |
| 322 | ARMP | Armata Pharmaceuticals, Inc. | 199.71M | -7.64% | 149,973 | 5.20M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 192.85M | -2.55% | 225,339 | - |
| 324 | MDWD | MediWound Ltd. | 188.16M | -3.43% | 84,516 | 14.48M |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 187.79M | 9.98% | 7,106,768 | 225.00K |
| 326 | ORMP | Oramed Pharmaceuticals Inc. | 187.03M | -0.65% | 281,071 | 2.00M |
| 327 | OKUR | OnKure Therapeutics, Inc. | 185.82M | 0.44% | 318,539 | - |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 185.31M | -0.86% | 366,793 | 76.38M |
| 329 | IPHA | Innate Pharma S.A. | 183.20M | 7.50% | 9,002 | 10.57M |
| 330 | CRBU | Caribou Biosciences, Inc. | 181.50M | 0.55% | 1,092,045 | 11.20M |
| 331 | MIST | Milestone Pharmaceuticals Inc. | 179.59M | - | 720,639 | 1.78M |
| 332 | CNTN | Canton Strategic Holdings, Inc. | 179.05M | -9.68% | 775,794 | - |
| 333 | LENZ | LENZ Therapeutics, Inc. | 175.58M | -4.92% | 1,309,233 | 20.99M |
| 334 | EQ | Equillium, Inc. | 175.14M | -4.81% | 915,289 | 4.39M |
| 335 | ACOG | Alpha Cognition Inc. | 172.02M | 0.13% | 45,945 | 10.83M |
| 336 | OTLK | Outlook Therapeutics, Inc. | 171.63M | -2.07% | 7,353,091 | 333.14K |
| 337 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 166.75M | -2.70% | 263,617 | - |
| 338 | NRXP | NRx Pharmaceuticals, Inc. | 165.34M | 1.94% | 620,725 | 2.29M |
| 339 | YDES | YD Bio Limited | 164.55M | 23.16% | 4,861,625 | 510.36K |
| 340 | MENS | Jyong Biotech Ltd. | 163.31M | -0.90% | 99,873 | - |
| 341 | ANTX | AN2 Therapeutics, Inc. | 158.83M | -0.23% | 130,086 | - |
| 342 | PYXS | Pyxis Oncology, Inc. | 155.85M | -6.46% | 1,221,572 | 13.86M |
| 343 | TLSA | Tiziana Life Sciences Ltd | 151.29M | -10.69% | 292,931 | - |
| 344 | HURA | TuHURA Biosciences, Inc. | 150.29M | -3.28% | 261,700 | - |
| 345 | KZIA | Kazia Therapeutics Limited | 149.46M | -1.28% | 52,628 | 1.27M |
| 346 | MOLN | Molecular Partners AG | 148.81M | 0.50% | 28,495 | 856.30K |
| 347 | CNTB | Connect Biopharma Holdings Limited | 148.59M | -4.07% | 365,509 | 233.00K |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 143.11M | -6.46% | 2,094,503 | - |
| 349 | SPRB | Spruce Biosciences, Inc. | 142.71M | -1.26% | 33,410 | 697.00K |
| 350 | AGEN | Agenus Inc. | 142.00M | -2.29% | 547,883 | 123.87M |
| 351 | ALDX | Aldeyra Therapeutics, Inc. | 137.53M | 0.44% | 1,199,752 | - |
| 352 | COYA | Coya Therapeutics, Inc. | 135.11M | -1.71% | 169,972 | 7.94M |
| 353 | GNLX | Genelux Corporation | 134.11M | 1.00% | 187,838 | 8.00K |
| 354 | CUE | Cue Biopharma, Inc. | 131.47M | 14.99% | 127,667 | 32.73M |
| 355 | PEPG | PepGen Inc. | 130.73M | 7.39% | 802,913 | - |
| 356 | AARD | Aardvark Therapeutics, Inc. | 130.68M | 5.09% | 174,861 | - |
| 357 | ENGN | enGene Therapeutics Inc. | 127.95M | 7.30% | 2,862,644 | - |
| 358 | GUTS | Fractyl Health, Inc. | 127.86M | 5.76% | 1,398,047 | 3.00K |
| 359 | NMAD | NOMAD Power Solutions, Inc. | 127.62M | 1.80% | 339,404 | - |
| 360 | SPRO | Spero Therapeutics, Inc. | 126.80M | -0.45% | 372,707 | 61.19M |
| 361 | PLYX | Polaryx Therapeutics, Inc. | 125.46M | -5.69% | 64,303 | - |
| 362 | ENLV | Enlivex Ltd. | 123.44M | -2.94% | 372,688 | - |
| 363 | PMN | ProMIS Neurosciences, Inc. | 122.95M | 2.70% | 55,355 | - |
| 364 | SEER | Seer, Inc. | 120.41M | 35.19% | 29,238,414 | 15.17M |
| 365 | NTHI | NeOnc Technologies Holdings, Inc. | 115.92M | 1.13% | 50,195 | 39.99K |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 112.88M | -1.99% | 1,789,698 | 70.00M |
| 367 | VANI | Vivani Medical, Inc. | 112.11M | 3.17% | 198,429 | - |
| 368 | KLRS | Kalaris Therapeutics, Inc. | 110.63M | -2.11% | 49,656 | - |
| 369 | CBUS | Cibus, Inc. | 107.63M | 1.44% | 204,678 | 4.29M |
| 370 | ATHE | Alterity Therapeutics Limited | 107.16M | 9.89% | 17,898 | 4.43M |
| 371 | PYPD | PolyPid Ltd. | 106.99M | 11.16% | 504,199 | - |
| 372 | VRCA | Verrica Pharmaceuticals Inc. | 105.31M | -0.16% | 40,367 | 37.16M |
| 373 | ONCY | Oncolytics Biotech Inc. | 105.06M | -2.10% | 807,666 | - |
| 374 | ANIX | Anixa Biosciences, Inc. | 103.77M | -6.73% | 272,802 | - |
| 375 | BMEA | Biomea Fusion, Inc. | 99.77M | -2.13% | 845,078 | - |
| 376 | RANI | Rani Therapeutics Holdings, Inc. | 98.24M | 2.81% | 950,740 | 3.17M |
| 377 | ATRA | Atara Biotherapeutics, Inc. | 98.03M | -6.61% | 80,376 | 23.14M |
| 378 | FBIO | Fortress Biotech, Inc. | 98.00M | -2.96% | 413,297 | 66.16M |
| 379 | ALPS | Alps Group Inc | 97.06M | -0.97% | 43,429 | 3.74M |
| 380 | RNTX | Rein Therapeutics Inc. | 95.83M | 3.88% | 162,251 | - |
| 381 | CGTX | Cognition Therapeutics, Inc. | 95.76M | -8.55% | 2,649,489 | - |
| 382 | INO | Inovio Pharmaceuticals, Inc. | 95.44M | -4.92% | 1,357,838 | 65.34K |
| 383 | GOSS | Gossamer Bio, Inc. | 95.28M | 12.53% | 16,580,519 | 55.54M |
| 384 | ACET | Adicet Bio, Inc. | 95.24M | 0.78% | 64,552 | - |
| 385 | ICCC | ImmuCell Corporation | 92.14M | -1.03% | 23,143 | 29.93M |
| 386 | CRDF | Cardiff Oncology, Inc. | 88.88M | 2.36% | 1,295,141 | 525.00K |
| 387 | MAIA | MAIA Biotechnology, Inc. | 88.77M | 0.69% | 555,923 | - |
| 388 | NRXS | NeurAxis, Inc. | 88.67M | 1.42% | 63,968 | 4.28M |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 87.34M | - | 35,516 | - |
| 390 | PTHS | Pelthos Therapeutics Inc. | 84.56M | -5.59% | 8,435 | 27.70M |
| 391 | ENTX | Entera Bio Ltd. | 84.18M | 3.01% | 573,078 | 42.00K |
| 392 | OKYO | OKYO Pharma Limited | 83.97M | 1.91% | 7,131 | - |
| 393 | ANVS | Annovis Bio, Inc. | 83.81M | 2.07% | 456,575 | - |
| 394 | RLYB | Rallybio Corporation | 83.29M | -0.63% | 19,058 | 858.00K |
| 395 | HRTX | Heron Therapeutics, Inc. | 82.13M | -1.03% | 2,630,878 | 150.71M |
| 396 | HYFT | MindWalk Holdings Corp. | 81.45M | 4.46% | 203,234 | 20.70M |
| 397 | CSBR | Champions Oncology, Inc. | 81.24M | 1.56% | 8,758 | 57.95M |
| 398 | IBIO | iBio, Inc. | 80.48M | -3.57% | 466,728 | 300.00K |
| 399 | LONA | LeonaBio, Inc. | 79.99M | -4.00% | 82,073 | - |
| 400 | GANX | Gain Therapeutics, Inc. | 77.20M | -5.24% | 621,810 | - |
| 401 | ACRV | Acrivon Therapeutics, Inc. | 76.19M | 3.49% | 384,452 | - |
| 402 | MCRB | Seres Therapeutics, Inc. | 74.66M | -0.39% | 31,504 | 1.15M |
| 403 | XBIT | XBiotech Inc. | 73.48M | 4.78% | 90,324 | - |
| 404 | OSTX | OS Therapies Incorporated | 71.71M | -14.81% | 2,138,894 | - |
| 405 | BYSI | BeyondSpring Inc. | 71.55M | -6.95% | 22,245 | 1.88M |
| 406 | CING | Cingulate Inc. | 71.39M | -1.49% | 217,531 | - |
| 407 | MNOV | MediciNova, Inc. | 70.88M | 0.70% | 43,655 | 596.64K |
| 408 | PLRX | Pliant Therapeutics, Inc. | 70.67M | -1.71% | 453,486 | - |
| 409 | EXOZ | eXoZymes, Inc. | 69.02M | -4.01% | 20,387 | -700.00 |
| 410 | TCRX | TScan Therapeutics, Inc. | 68.62M | -0.94% | 418,938 | 9.14M |
| 411 | IMA | ImageneBio, Inc. | 67.00M | 1.89% | 4,868 | 800.00K |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 64.26M | -1.23% | 170,940 | - |
| 413 | ATYR | aTyr Pharma, Inc. | 64.12M | 10.36% | 1,664,937 | 190.00K |
| 414 | EDSA | Edesa Biotech, Inc. | 64.11M | -3.87% | 65,666 | - |
| 415 | ELTX | Elicio Therapeutics, Inc. | 62.84M | 2.33% | 1,367,832 | - |
| 416 | FLNA | Filana Therapeutics, Inc. | 60.38M | 1.63% | 217,046 | - |
| 417 | CNTX | Context Therapeutics Inc. | 58.58M | -2.46% | 1,509,133 | - |
| 418 | INKT | MiNK Therapeutics, Inc. | 57.59M | -0.94% | 9,009 | - |
| 419 | XLO | Xilio Therapeutics, Inc. | 56.48M | 3.17% | 10,096 | 53.48M |
| 420 | IMMP | Immutep Limited | 56.25M | 4.98% | 576,395 | 5.28M |
| 421 | BOLD | Boundless Bio, Inc. | 56.16M | - | 384,495 | - |
| 422 | VRXA | Veraxa Biotech AG | 55.23M | 7.35% | 1,036,962 | - |
| 423 | TIL | Instil Bio, Inc. | 52.36M | -0.13% | 11,111 | - |
| 424 | IBO | Impact BioMedical Inc. | 51.43M | 1.06% | 62,864 | 39.00K |
| 425 | MREO | Mereo BioPharma Group plc | 50.54M | -5.41% | 1,075,617 | 500.00K |
| 426 | LTRN | Lantern Pharma Inc. | 50.14M | -1.01% | 104,766 | - |
| 427 | HYPD | Hyperion DeFi, Inc. | 49.41M | 4.82% | 408,789 | 1.04M |
| 428 | RADX | Radiopharm Theranostics Limited | 49.19M | -0.46% | 6,952 | 10.86M |
| 429 | CRVO | CervoMed Inc. | 48.29M | 0.56% | 772,954 | 2.09M |
| 430 | ABVC | ABVC BioPharma, Inc. | 48.01M | 5.56% | 325,057 | 797.92K |
| 431 | PDSB | PDS Biotechnology Corporation | 47.23M | -0.82% | 286,042 | - |
| 432 | MGX | Metagenomi Therapeutics, Inc. | 47.06M | -0.79% | 136,978 | 22.33M |
| 433 | ELOX | Eloxx Pharmaceuticals, Inc. | 46.66M | -8.00% | 28,780 | - |
| 434 | DWTX | Dogwood Therapeutics, Inc. | 46.41M | -7.38% | 271,869 | - |
| 435 | VERU | Veru Inc. | 45.42M | -7.52% | 380,805 | 16.89M |
| 436 | INMB | INmune Bio Inc. | 44.26M | -2.06% | 625,267 | 50.00K |
| 437 | ESLA | Estrella Immunopharma, Inc. | 43.89M | 3.82% | 37,044 | - |
| 438 | APLM | Apollomics, Inc. | 42.52M | -1.02% | 12,617 | 8.84M |
| 439 | RNXT | RenovoRx, Inc. | 41.59M | 0.24% | 258,087 | 1.49M |
| 440 | GRCE | Grace Therapeutics, Inc. | 41.17M | 6.75% | 273,822 | - |
| 441 | GNTA | Genenta Science S.p.A. | 39.63M | -2.33% | 104,167 | - |
| 442 | NTRB | Nutriband Inc. | 38.17M | 2.61% | 21,713 | 1.80M |
| 443 | ALGS | Aligos Therapeutics, Inc. | 36.20M | 4.65% | 3,160,306 | 4.71M |
| 444 | DYAI | Dyadic International, Inc. | 35.26M | 2.88% | 45,091 | 3.81M |
| 445 | NNVC | NanoViricides, Inc. | 34.17M | 12.78% | 602,830 | - |
| 446 | SNTI | Senti Biosciences Holdings, Inc. | 33.64M | 0.93% | 152,302 | 38.00K |
| 447 | ACTU | Actuate Therapeutics, Inc. | 33.50M | -7.89% | 69,971 | - |
| 448 | LITS | Lite Strategy, Inc. | 33.20M | 2.66% | 192,895 | - |
| 449 | DARE | Daré Bioscience, Inc. | 31.16M | -0.48% | 53,563 | 1.16M |
| 450 | BCTX | BriaCell Therapeutics Corp. | 30.59M | 7.36% | 358,827 | - |
| 451 | LSTA | Lisata Therapeutics, Inc. | 30.51M | 0.60% | 9,269 | 170.00K |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 30.15M | -2.04% | 144,720 | 90.00K |
| 453 | GRDX | GridAI Technologies Corp. | 30.04M | 2.61% | 98,788 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 29.35M | -4.98% | 19,562 | 7.44M |
| 455 | SER | Serina Therapeutics, Inc. | 29.25M | 2.63% | 72,097 | 130.00K |
| 456 | KALA | KALA BIO, Inc. | 28.63M | -8.33% | 496,981 | - |
| 457 | EVAX | Evaxion A/S | 28.52M | 0.29% | 11,701 | 7.53M |
| 458 | PLRZ | Polyrizon Ltd. | 28.47M | 10.20% | 63,174 | - |
| 459 | IGC | IGC Pharma, Inc. | 28.13M | 0.04% | 344,002 | 1.11M |
| 460 | PSTV | Plus Therapeutics, Inc. | 27.88M | 1.76% | 165,698 | 5.18M |
| 461 | BRNS | Barinthus Biotherapeutics plc | 25.76M | 1.68% | 98,355 | 14.97M |
| 462 | SKYE | Skye Bioscience, Inc. | 24.72M | 0.40% | 70,643 | - |
| 463 | MRKR | Marker Therapeutics, Inc. | 24.68M | 0.68% | 148,176 | 3.55M |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 24.60M | -1.69% | 107,632 | - |
| 465 | TVGN | Tevogen Bio Holdings Inc. | 24.54M | 1.56% | 3,418 | - |
| 466 | PLUR | Pluri Inc. | 23.52M | 3.32% | 357,438 | 1.08M |
| 467 | CELU | Celularity Inc. | 23.16M | 29.09% | 970,643 | 26.55M |
| 468 | VYNE | VYNE Therapeutics Inc. | 22.27M | -1.81% | 85,410 | 454.00K |
| 469 | CVM | CEL-SCI Corporation | 22.20M | 11.40% | 968,117 | - |
| 470 | CLRB | Cellectar Biosciences, Inc. | 22.14M | -1.42% | 30,988 | - |
| 471 | QNTM | Quantum BioPharma Ltd. | 21.40M | -1.99% | 79,707 | - |
| 472 | NCEL | NewcelX Ltd. | 21.02M | 1.43% | 45,127 | - |
| 473 | LGVN | Longeveron Inc. | 20.52M | -5.94% | 983,203 | 1.22M |
| 474 | LPCN | Lipocine Inc. | 20.36M | 3.35% | 36,465 | 2.00M |
| 475 | ATOS | Atossa Therapeutics, Inc. | 19.63M | 7.55% | 228,476 | - |
| 476 | PTN | Palatin Technologies, Inc. | 19.32M | -5.00% | 12,068 | 12.88M |
| 477 | AEON | AEON Biopharma, Inc. | 19.20M | 2.08% | 12,368 | - |
| 478 | ICU | SeaStar Medical Holding Corporation | 19.14M | -3.25% | 134,309 | 1.44M |
| 479 | ALLR | Allarity Therapeutics, Inc. | 19.09M | -8.40% | 150,987 | 345.00K |
| 480 | TVRD | Tvardi Therapeutics, Inc. | 18.86M | -0.50% | 74,864 | - |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 18.59M | 1.78% | 65,267 | -13.27K |
| 482 | AKTX | Akari Therapeutics, Plc | 18.50M | 1.54% | 159,979 | - |
| 483 | GTBP | GT Biopharma, Inc. | 17.66M | 3.82% | 1,418,343 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 17.38M | -5.42% | 320,543 | - |
| 485 | CMMB | Chemomab Therapeutics Ltd. | 17.28M | 5.73% | 350,726 | - |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 16.68M | 5.73% | 105,307 | 5.61M |
| 487 | QNCX | Quince Therapeutics, Inc. | 16.61M | -1.45% | 18,913 | - |
| 488 | MLEC | Moolec Science SA | 16.04M | -3.20% | 1,585 | 7.83M |
| 489 | TPST | Tempest Therapeutics, Inc. | 15.84M | -1.83% | 99,809 | - |
| 490 | BIVI | BioVie Inc. | 15.84M | 7.69% | 162,431 | - |
| 491 | HIND | Vyome Holdings, Inc. | 15.65M | -3.04% | 12,883 | 152.72K |
| 492 | CALC | CalciMedica, Inc. | 15.61M | 2.34% | 421,973 | - |
| 493 | HOWL | Werewolf Therapeutics, Inc. | 15.55M | -5.99% | 574,225 | 1.14M |
| 494 | PASG | Passage Bio, Inc. | 15.08M | 0.43% | 19,864 | - |
| 495 | CYCN | Cyclerion Therapeutics, Inc. | 14.67M | 0.87% | 4,990 | 1.99M |
| 496 | COCP | Cocrystal Pharma, Inc. | 14.34M | - | 14,104 | 225.00K |
| 497 | INAB | IN8bio, Inc. | 14.18M | 1.41% | 52,645 | - |
| 498 | LNAI | Lunai Bioworks Inc. | 14.01M | -3.44% | 44,109 | 20.94K |
| 499 | LEXX | Lexaria Bioscience Corp. | 13.87M | -0.11% | 12,707 | 368.00K |
| 500 | BCDA | BioCardia, Inc. | 13.31M | -2.50% | 259,909 | 3.00K |